Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(3-(2-methylsulfonylphenothiazin-10-yl) Propyl)isonipecotinamide
2. Metopimazine Hydrochloride
3. Vogalene
1. 14008-44-7
2. Vogalene
3. Exp 999
4. 1-[3-(2-methylsulfonylphenothiazin-10-yl)propyl]piperidine-4-carboxamide
5. Exp-999
6. 4-piperidinecarboxamide, 1-[3-[2-(methylsulfonyl)-10h-phenothiazin-10-yl]propyl]-
7. 1-(3-(2-(methylsulfonyl)phenothiazin-10-yl)propyl)isonipecotamide
8. 238s75v9av
9. 4-piperidinecarboxamide, 1-(3-(2-(methylsulfonyl)-10h-phenothiazin-10-yl)propyl)-
10. Rp-9965
11. Nortrip
12. 1-[3-[2-(methylsulfonyl)phenothiazin-10-yl]propyl]isonipecotamide
13. 1-(3-(2-(methylsulfonyl)-10h-phenothiazin-10-yl)propyl)-4-piperidinecarboxamide
14. 1-[3-[2-(methylsulfonyl)-10h-phenothiazin-10-yl]propyl]-4-piperidinecarboxamide
15. Metopimazina
16. Metopimazinum
17. Metopimazinum [inn-latin]
18. Metopimazina [inn-spanish]
19. Rp 9965
20. Einecs 237-818-4
21. Brn 4278585
22. Unii-238s75v9av
23. Metopimazine [usan:inn:ban]
24. 1-(3-(2-(methylsulfonyl)-10h-phenothiazin-10-yl)propyl)piperidin-4-carboxamide
25. 1-[3-[2-(methylsulfonyl)-10h-phenothiazin-10-yl]propyl]piperidin-4-carboxamide
26. 2-methylsulfonyl-10-(3-(4-carbamoylpiperidino)propyl)phenothiazine
27. Metopimazine [mi]
28. 10-(3-(4-carbamoylpiperidine)propyl)-2-(methanesulfonyl)phenothiazine
29. Phenothiazine, 10-(3-(4'-carbamoylpiperidino)propyl)-2-methylsulfonyl-
30. Metopimazine (usan/inn)
31. Metopimazine [inn]
32. 1-(3-(2-(methylsulfonyl)phenothiazin-10-yl)propyl)-4-piperidinecarboxamide
33. 4-piperidinecarboxamide, 1-(3-(2-(methanesulfonyl)phenothiazin-10-yl)propyl)-
34. Metopimazine [usan]
35. Schembl49905
36. Metopimazine [mart.]
37. Metopimazine [who-dd]
38. Chembl398615
39. Bdbm82383
40. Gtpl11140
41. Dtxsid80161224
42. Chebi:135726
43. Bdbm179867
44. Zinc537996
45. Cas_26388
46. Ng-101
47. Nsc_26388
48. Akos005065914
49. Isonipecotamide, 1-(3-(2-(methylsulfonyl)phenothiazin-10-yl)propyl)-
50. Bcp9000921
51. Db13591
52. Us9132134, Metopimazine (ng101)
53. Ft-0672379
54. Ft-0672380
55. D05010
56. Q194682
57. J-007351
58. 1-(3-[2-(methylsulfonyl)-10h-phenothiazin-10-yl]propyl)-4-piperidinecarboxamide #
Molecular Weight | 445.6 g/mol |
---|---|
Molecular Formula | C22H27N3O3S2 |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 445.14938408 g/mol |
Monoisotopic Mass | 445.14938408 g/mol |
Topological Polar Surface Area | 117 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 703 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
A - Alimentary tract and metabolism
A04 - Antiemetics and antinauseants
A04A - Antiemetics and antinauseants
A04AD - Other antiemetics
A04AD05 - Metopimazine
M2i Group, an integrated CDMO, is your French partner for development & manufacturing in fine chemistry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 892
Submission : 1965-05-12
Status : Inactive
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0104
Address of the Firm :
Date of Issue : 2022-06-08
Valid Till : 2025-07-07
Written Confirmation Number : WC-0104
Address of the Firm :
Date of Issue : 2022-06-08
Valid Till : 2025-06-25
Written Confirmation Number : WC-0107
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 892
Submission : 1965-05-12
Status : Inactive
Type : II
Date of Issue : 2022-06-08
Valid Till : 2025-06-25
Written Confirmation Number : WC-0107
Address of the Firm : Plot No. 75/76, Chikhloli, MIDC, Ambernath (W), Dist- Thane
Date of Issue : 2022-06-08
Valid Till : 2025-07-07
Written Confirmation Number : WC-0104
Address of the Firm : #125 & 126, Sipcot Industrial Complex, Hosur-635 126, Tamilnadu
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0104
Address of the Firm : #125 & 126, Sipcot Industrial Complex, Hosur-635 126, Tamilnadu
NDC Package Code : 47848-051
Start Marketing Date : 2016-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84644-051
Start Marketing Date : 2016-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
M2i Group, an integrated CDMO, is your French partner for development & manufacturing in fine chemistry.
About the Company : Integrated solutions for all your projects.
M2i Group provides integrated solutions for all your projects. We offer our clients an integrated partner, from early development...
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
About the Company : From the day we founded Aesica in 2004, we have been committed to being fast, flexible, innovative and reliable. Qualities which are helping to make us one of the world’s leadin...
About the Company : Axyntis Group, founded in 2007, is France’s leading independent multi-site player in fine chemicals with a €90 million annual turnover. Axyntis has become a key producer of API...
About the Company : Centaur accepts change as a constant, and continuously innovates to remain significant. Centaur has built knowledge sharing relationships with the pharmaceutical majors in areas of...
About the Company : As an EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979 as Calcium Ind...
About the Company : Lab-Service, France.Since 1981 we are subcontractor for particle size determination and micronisation, milling, sieving for pharmaceutical and fine chimical industry.Able to micron...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 39546-32-2
End Use API : Metopimazine
About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...
CAS Number : 7643-08-5
End Use API : Metopimazine
About The Company : Anupam Rasayan India Limited was started in 1976 and we are 36 years old. ISO 9001:2008 and ISO 14001:2004 certified chemical company with sound technology, en...
CAS Number : 39546-32-2
End Use API : Metopimazine
About The Company : Epoch-Labs is a Hyderabad, India based Research Organization that gives science administrations to expansive pharmaceutical organization, agrochemical organizat...
Regulatory Info :
Registration Country : France
Brand Name :
Dosage Form : Oro-Dispersible Tablet
Dosage Strength : 7.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Metopimazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metopimazine, including repackagers and relabelers. The FDA regulates Metopimazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metopimazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Metopimazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Metopimazine supplier is an individual or a company that provides Metopimazine active pharmaceutical ingredient (API) or Metopimazine finished formulations upon request. The Metopimazine suppliers may include Metopimazine API manufacturers, exporters, distributors and traders.
click here to find a list of Metopimazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Metopimazine DMF (Drug Master File) is a document detailing the whole manufacturing process of Metopimazine active pharmaceutical ingredient (API) in detail. Different forms of Metopimazine DMFs exist exist since differing nations have different regulations, such as Metopimazine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Metopimazine DMF submitted to regulatory agencies in the US is known as a USDMF. Metopimazine USDMF includes data on Metopimazine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Metopimazine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Metopimazine suppliers with USDMF on PharmaCompass.
A Metopimazine written confirmation (Metopimazine WC) is an official document issued by a regulatory agency to a Metopimazine manufacturer, verifying that the manufacturing facility of a Metopimazine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Metopimazine APIs or Metopimazine finished pharmaceutical products to another nation, regulatory agencies frequently require a Metopimazine WC (written confirmation) as part of the regulatory process.
click here to find a list of Metopimazine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metopimazine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metopimazine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metopimazine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metopimazine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metopimazine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metopimazine suppliers with NDC on PharmaCompass.
Metopimazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metopimazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metopimazine GMP manufacturer or Metopimazine GMP API supplier for your needs.
A Metopimazine CoA (Certificate of Analysis) is a formal document that attests to Metopimazine's compliance with Metopimazine specifications and serves as a tool for batch-level quality control.
Metopimazine CoA mostly includes findings from lab analyses of a specific batch. For each Metopimazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metopimazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Metopimazine EP), Metopimazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metopimazine USP).
LOOKING FOR A SUPPLIER?